New pill aims to help seniors regain strength and mobility
Disease control
Not yet recruiting
This study tests an experimental oral medication, PLH-2301, in 168 adults aged 65 and older who have sarcopenia (age-related muscle loss). Participants will take either a placebo or one of three doses of the drug daily for 12 weeks. The main goal is to see if the drug improves ph…
Phase: PHASE2 • Sponsor: Pluto Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC